---
edited: 2024-03-02
tags:
---
### Pathophysiology
- Deficiency of glucocerebrosidase enzyme leads to the accumulation of glucocerebroside primarily in macrophages (Gaucher cells), affecting various organs and tissues
- Organs involved
	- Brain
	- Bones
	- Liver, spleen
	- Bone marrow suppression 

| Types                                                                      | Clinical Features                                                                                                                 | Pathophysiology                                                        | Management                                                                                  |
| -------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------- | ---------------------------------------------------------------------- | ------------------------------------------------------------------------------------------- |
| - Type 1: Non-neuronopathic Gaucher disease<br><br>                        | - Type 1:<br>  - [[Hepatosplenomegaly]]<br>  - [[Anemia]]<br>  - [[Thrombocytopenia]]<br>  - Bone pain and fractures<br><br>      | Primarily affects the liver, spleen, and bone marrow<br>               |                                                                                             |
| - Type 2: Acute neuronopathic Gaucher disease (infantile form)             | - Severe neurologic involvement<br>- Rapidly progressive neurologic decline<br>- [[Hepatosplenomegaly]]<br>- Respiratory distress | Also affect the central nervous system, leading to neurologic symptoms |                                                                                             |
| - Type 3: Chronic neuronopathic Gaucher disease (juvenile and adult forms) | - Variable neurologic symptoms<br>- Hepatosplenomegaly<br>- [[Oculomotor apraxia]]<br>- Bone involvement (osteopenia, fractures)  | Also affect the central nervous system, leading to neurologic symptoms | - Bone marrow transplantation: Curative option for severe cases, particularly types 2 and 3 |
### Diagnostics
- Measurement of glucocerebrosides livers in leukocytes or skin fibroblasts
- Serum chitotriosidase levels are increased 
- USG for [[Hepatosplenomegaly]]
- [[Neuorophthalmology]]
- [[Hearing assessment]] 
- [[EEG]] 
### Management
 - [[Enzyme replacement therapy (ERT]]): Recombinant glucocerebrosidase enzyme administered intravenously to reduce substrate accumulation
- [[Substrate reduction therapy (SRT)]]: Inhibitors of glucosylceramide synthase to decrease substrate synthesis
- Symptomatic management: Pain relief, blood transfusions for anemia, management of skeletal complications, supportive care for neurologic symptoms
- [[Splenectomy]]
- [[Allogenic bone marrow transplantation]] 
---
